ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Indianapolis, IN, USA:

Olaparib In Metastatic Breast Cancer

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Indianapolis, Indiana, United States and 19 other locations

therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...

Enrolling
Breast Cancer
Hormone Receptor Positive Breast Cancer
Drug: ADJUVANT ENDOCRINE THERAPY
Combination Product: Pertuzumab+TRASTUZUMAB

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Indianapolis, Indiana, United States and 25 other locations

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...

Active, not recruiting
Breast Cancer
Drug: Pertuzumab
Drug: Trastuzumab

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Indianapolis, Indiana, United States and 9 other locations

This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...

Enrolling
Breast Cancer
Drug: Avelumab
Drug: Palbociclib

Phase 2

Abramson Cancer Center at Penn Medicine
Abramson Cancer Center at Penn Medicine

Indianapolis, Indiana, United States and 6 other locations

carboplatin monotherapy vs. carboplatin combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast...

Enrolling
Estrogen-receptor-low Breast Cancer
Metastatic Breast Cancer
Drug: Tocilizumab
Drug: Carboplatin

Phase 2

Kathy Miller

Indianapolis, Indiana, United States and 2 other locations

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...

Active, not recruiting
Breast Cancer Metastatic
Biological: Pelareorep
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Indianapolis, Indiana, United States and 17 other locations

This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...

Active, not recruiting
Breast Cancer
Drug: Avelumab
Drug: Trastuzumab

Phase 2

Adrienne G. Waks

Indianapolis, Indiana, United States and 16 other locations

works in treating patients with stage IV triple negative breast cancer. Drugs used in chemotherapy, such as carboplatin, work in di...

Active, not recruiting
Triple Negative Breast Cancer
Invasive Breast Cancer
Other: Quality-of-Life Assessment
Drug: Carboplatin

Phase 2

Vanderbilt University Medical Center
Vanderbilt University Medical Center

Indianapolis, Indiana, United States and 5 other locations

The purpose of this study is to determine if enzalutamide given in combination with exemestane is safe and effective in patients with advanced breast...

Active, not recruiting
Breast Cancer
Drug: Enzalutamide
Drug: exemestane

Phase 2

Pfizer
Pfizer

Indianapolis, Indiana, United States and 128 other locations

This research study is studying three combinations of drugs as treatments for breast cancer.The drugs involved in this study are:* ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Fulvestrant
Drug: Avelumab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Indianapolis, Indiana, United States and 21 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems